SCHEMBL29453739

SCHEMBL29453739

N#Cc1ccc(CC2(C#N)CCN(C(=O)c3cccnc3-c3ccncc3)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 10/20 0.62
▸ CYP3A4 P08684 6/20 0.62
▸ CYP2C9 P11712 4/20 0.62
▸ CYP2C19 P33261 3/20 0.62
▸ CYP2C8 P10632 1/20 0.62
▸ CYP2D6 P10635 4/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ SLC6A7 Q99884 1/20 0.41
▸ ABCG2 Q9UNQ0 1/20 0.41
▸ HCRTR1 O43613 1/20 0.41
▸ HCRTR2 O43614 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719479 1.00 CYP46A1 (0.62) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL29453769 0.93 CYP46A1 (0.68) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22719284 0.93 CYP46A1 (0.68) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22719476 0.91 CYP46A1 (0.74) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL29453767 0.91 CYP46A1 (0.74) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL29453641 0.91 CYP46A1 (0.62) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL29453674 0.91 CYP46A1 (0.68) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22719484 0.91 CYP46A1 (0.68) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22719455 0.91 CYP46A1 (0.62) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL14840729 0.90 CYP46A1 (0.78) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback